Article
Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
Oncotarget - 6 Dec 2016
He Feng, Chen Huacui, Yang Ping, Wu Qianlong, Zhang Tong, Wang Chengxing, Wei Jianchang, Chen Zhuanpeng, Hu He, Li Wanglin, Cao Jie
Abstract excerpt
High levels of angiogenesis, metastasis and chemoresistance are major clinical features of colorectal cancer (CRC), a lethal disease with a high incidence worldwide. Aberrant activation of Wnt/β-catenin pathway contributes to CRC progression. However, little is known about regulatory mechanisms of the β-catenin activity in cancer progression. Here we report that Gankyrin was markedly upregulated in primary tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
